Female mammalian germ cells silence one X chromosome during early development and then reactivate it around the time of meiotic entry, but whether this temporally ordered cycle is causally required for germ cells to mature and enter meiosis, or merely accompanies competence, is unknown. Severino and colleagues (EMBO Journal, 2022) showed with an engineered mouse in vitro system (XRep) that primordial germ cell-like cells that never inactivated an X, or that reactivated it too early, fail to enter a normal meiotic trajectory. Since then, single-cell studies have mapped the in vivo kinetics of X-reactivation in fine detail, and defined signalling systems now support meiotic prophase in vitro without ovarian somatic cells, yet no study has directly tested whether blocking X-inactivation or X-reactivation changes meiotic outcome, which X-linked dosage-sensitive genes mediate the defect, or what somatic signal drives X-reactivation in vivo. A 2026 review confirms that the functional, causal role of the X-inactivation/reactivation 'epigenetic yoyo' in the germ cell lineage remains open.

Background

In female mammals, one of the two X chromosomes is transcriptionally silenced in somatic cells by X-chromosome inactivation (XCI), the dosage-compensation mechanism proposed by Mary Lyon in 1961, which is initiated in early development by the long non-coding RNA Xist and maintained through heterochromatin. The germ line is exceptional: primordial germ cells (PGCs), the embryonic precursors of eggs and sperm, must erase this imprint. X-chromosome reactivation (XCR) — the re-expression of the previously silent X — initiates in nascent PGCs during their migration (Sugimoto and Abe, 2007) and is thought to be enhanced by a female-specific signal from the gonadal somatic environment (Chuva de Sousa Lopes et al., 2008), so that reactivation is largely complete in oogonia around the entry into meiosis. Whether this inactivation-then-reactivation cycle is functionally important for the developing germ cells themselves has been hard to test in vivo, because PGCs are rare and their X-status could not be prospectively traced. To overcome this, Severino et al. (2022) built XRep, a mouse embryonic stem cell line carrying dual X-linked fluorescent reporters (XGFP on one X, XTomato on the other) plus a truncation of Tsix (the antisense regulatory RNA that normally represses Xist) that forces non-random XCI, allowing fluorescence-activated sorting of primordial germ cell-like cells (PGCLCs — PGC-like cells obtained in vitro by inducing the germ-cell fate specifying transcription factors BLIMP1, PRDM14 and TFAP2C) according to their X-chromosome state. Sorting revealed that PGCLCs that had never inactivated an X (XGFP+, i.e. two active X chromosomes) or that reactivated an X prematurely showed an abnormal mitotic character, ESC-like pluripotency features, and strongly reduced capacity to enter meiosis and form oocytes in reconstituted ovary (rOvary) cultures, whereas PGCLCs with a moderate inactivation followed by gradual reactivation progressed efficiently through meiotic prophase I (the first stage of meiosis, tracked by the synaptonemal complex protein SYCP3). Several mechanistic explanations were proposed but not tested: double dose of X-linked dosage-sensitive genes such as Dusp9 (a MAPK phosphatase regulator) or Klhl13 (a pluripotency-promoting factor), interference with the DNA-methylation programme that normally represses late germ-cell and meiotic genes, and a possible need to equalize chromatin between the two X chromosomes before X-X pairing in meiotic prophase. Related work in other contexts has identified regulators of XCR during induced pluripotent stem cell reprogramming (the interferon-gamma pathway, Barrero et al. 2024; cohesin, Generoso et al. 2023), but none of these address germ cells.

Problem Statement

Determine experimentally whether — and through which molecular effectors — the temporally ordered cycle of X-chromosome inactivation followed by X-chromosome reactivation is functionally required for female mouse germ cells to acquire meiotic competence and progress through meiosis, or whether X-chromosome status is only a diagnostic correlate of competence. As framed by Severino et al. (2022), the open questions are: (1) whether X-inactivation actively drives proper primordial germ cell development or merely marks cells that are competent for other reasons; (2) which X-linked dosage-sensitive genes (candidates including the MAPK regulator Dusp9 and the pluripotency-promoting factor Klhl13) are responsible for the aberrant phenotype of PGCLCs that retained two active X chromosomes; (3) whether X-reactivation is required for female germ cells to progress through meiosis or whether reactivation and meiotic entry are functionally unrelated; (4) the molecular identity of the female-specific gonadal somatic signal that promotes X-reactivation in vivo; and (5) whether the in vitro conclusions hold in vivo, in particular whether PGCs that fail to undergo X-inactivation exist in the developing embryo and what fate they commit to. The causal question in (1) and (3) — whether the cycle is functionally required or only a diagnostic correlate — is settled only by a general causal conclusion, not by any single assay.

References

  1. Severino J, Bauer M, Mattimoe T, Arecco N, Cozzuto L, Lorden P, Hamada N, Nosaka Y, Nagaoka SI, Audergon P, Tarruell A, Heyn H, Hayashi K, Saitou M, Payer B (2022). Controlled X-chromosome dynamics defines meiotic potential of female mouse in vitro germ cells. The EMBO Journal 41(12):e109457. doi:10.15252/embj.2021109457 https://doi.org/10.15252/embj.2021109457
  2. Lyon MF (1961). Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190(4773):372-373. doi:10.1038/190372a0 https://doi.org/10.1038/190372a0
  3. Sugimoto M, Abe K (2007). X chromosome reactivation initiates in nascent primordial germ cells in mice. PLoS Genetics 3(7):e116. doi:10.1371/journal.pgen.0030116 https://doi.org/10.1371/journal.pgen.0030116
  4. Chuva de Sousa Lopes SM, Hayashi K, Shovlin TC, Mifsud W, Surani MA, McLaren A (2008). X chromosome activity in mouse XX primordial germ cells. PLoS Genetics 4(2):e30. doi:10.1371/journal.pgen.0040030 https://doi.org/10.1371/journal.pgen.0040030
  5. Chang YW, Overeem AW, Roelse CM, Fan X, Freund C, Chuva de Sousa Lopes SM (2021). Tissue of origin, but not XCI state, influences germ cell differentiation from human pluripotent stem cells. Cells 10(9):2400. doi:10.3390/cells10092400 https://doi.org/10.3390/cells10092400
  6. Yokobayashi S, Yabuta Y, Nakagawa M, Okita K, Hu B, Murase Y, Nakamura T, Bourque G, Majewski J, Yamamoto T, Saitou M (2021). Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells. Cell Reports 37(5):109909. doi:10.1016/j.celrep.2021.109909 https://doi.org/10.1016/j.celrep.2021.109909
  7. Mattimoe T, Payer B (2023). The compleX balancing act of controlling X-chromosome dosage and how it impacts mammalian germline development. Biochemical Journal 480(8):521-537. doi:10.1042/BCJ20220450 https://doi.org/10.1042/BCJ20220450
  8. Aizawa E, Ozonov EA, Kawamura YK, Dumeau CE, Nagaoka S, Kitajima TS, Saitou M, Peters AHFM, Wutz A (2023). Epigenetic regulation limits competence of pluripotent stem cell-derived oocytes. The EMBO Journal 42(23):e113955. doi:10.15252/embj.2023113955 https://doi.org/10.15252/embj.2023113955
  9. Generoso SF, Neguembor MV, Hershberg EA, Sadreyev RI, Kurimoto K, Yabuta Y, Ricci R, Audergon P, Bauer M, Saitou M, Hochedlinger K, Beliveau BJ, Cosma MP, Lee JT, Payer B (2023). Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming. Proceedings of the National Academy of Sciences USA 120(4):e2213810120. doi:10.1073/pnas.2213810120 https://doi.org/10.1073/pnas.2213810120
  10. Liu Y, Lau X, Munusamy P, Abascal Sherwell Sanchez C, Snell D, Sangrithi M (2025). Single-cell RNA-seq identifies protracted mouse germline X chromosome reactivation dynamics directed by a PRC2-dependent mechanism. Developmental Cell 60(9):1321-1335.e5. doi:10.1016/j.devcel.2024.12.028 https://doi.org/10.1016/j.devcel.2024.12.028
  11. Roidor C, Syx L, Beyne E, Raynaud P, Zielinski D, Teissandier A, Lee C, Walter M, Servant N, Chebli K, Bourc'his D, Surani MA, Borensztein M (2025). Temporal and regional X-linked gene reactivation in the mouse germline reveals site-specific retention of epigenetic silencing. Nature Structural & Molecular Biology 32(5):926-939. doi:10.1038/s41594-024-01469-2 https://doi.org/10.1038/s41594-024-01469-2
  12. Nosaka Y, Nagano M, Yabuta Y, Nakakita B, Nagaoka SI, Okamoto I, Sasada H, Mizuta K, Umemura F, Kuma H, Okochi Y, Katou Y, de Massy B, Inoue A, Horie A, Mandai M, Ohta H, Saitou M (2025). Generation of germinal-vesicle oocytes from mouse embryonic stem cells under an ovarian soma-free condition. Developmental Cell 60(21):2976-2994.e13. doi:10.1016/j.devcel.2025.06.008 https://doi.org/10.1016/j.devcel.2025.06.008
  13. Zussman JW, Laird DJ (2025). In vitro oogenesis breaks free of the ovary. Developmental Cell 60(21):2843-2845. doi:10.1016/j.devcel.2025.09.020 https://doi.org/10.1016/j.devcel.2025.09.020
  14. Barrero M, Lazarenkov A, Blanco E, Palma LG, Lopez-Rubio AV, Bauer M, Bigas A, Di Croce L, Sardina JL, Payer B (2024). The interferon gamma pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming. Science Advances 10(32):eadj8862. doi:10.1126/sciadv.adj8862 https://doi.org/10.1126/sciadv.adj8862
  15. Moyano Rodriguez Y, Borensztein M (2026). Reprogramming the inactive X chromosome: dynamics and insights from the germline. Biochemical Society Transactions 54(3):317-332. doi:10.1042/BST20250549 https://doi.org/10.1042/BST20250549
  16. Llonch S, Pinel L, Mattimoe T, Severino J, Zambelli F, Mallol A, Freire Carvalho K, Batlle-Morera L, Vassena R, Payer B (2026). Generation of human primordial germ cell-like cells from cumulus and blood cell-derived isogenic human induced pluripotent stem cells. Biology of Reproduction 115(2):634-645. doi:10.1093/biolre/ioag101 https://doi.org/10.1093/biolre/ioag101